New potent sialyltransferase inhibitors - Synthesis of donor and of transition-state analogues of sialyl donor CMP-Neu5Ac

Chemistry - A European Journal

Volumn 4, Issue 6, 1998, Pages 1106-1115

  Amann, Franz ^a   Schaub, Christoph ^a   Müller, Bernd ^a   Schmidt, Richard R ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Enzyme inhibitors; Neuraminic acids; Substrate analogues; Transferases; Transition states

Indexed keywords

EID: 0031804190     PISSN: 09476539     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3765(19980615)4:6<1106::AID-CHEM1106>3.0.CO;2-7     Document Type: Article

References (51)

1. a) A. Rosenberg, in Biology of Sialic Acids, Plenum, New York, 1995;
2. b) F. Dall'Olio, N. Malagolini, F. Serafini-Cessi, Int. J. Cancer 1992, 50, 325-330;
3. c) J. Morgenthaler, J. Kemmner, R. Brossmer, Biochem. Biophys. Res. Commun. 1990, 171, 860-866.
4. a) R.J. Bernacki, Science 1977, 195, 557-580;
5. b) Q. Zhou, S. Hakomori, K. Kitamura, Y. Igarashi, J. Biol. Chem. 1994, 269, 1959-1965.
6. a) M. Fogel, P. Alvogt, V. Schirrmacher, J. Exp. Med. 1983, 157, 371-376;
7. b)S. Hakomori, Chem. Phys. Lipids 1986, 42, 209-233;
8. c) J. W. Dennis, in Cell Surface Carbohydrates and Cell Development (Ed. : M. Fukada), CRC, Boca Raton, 1991, pp. 174-175.
9. a) F. Dall'Olio, N. Malagolini, G. DiStefanno, F. Minni, D. Marrano, F. Serafini-Cessi, Int. J. Cancer 1989, 44, 434-439;
10. b) P. Gessner, S. Riedl, A. Quentmaier, W. Kemmner, Cancer Lett, 1993, 75, 143-149;
11. c) W. Kemmner, D. Kruck, P. Schlag, Clin. Exp. Metastasis 1994, 12, 245 - 254.
12. A. Harduin-Lepers, M. A. Recchi, P. Delannoy, Glycobiology 1995, 5, 741-758.
13. a) W. Korytnyk, N. Angelino, W. Klohs, R. J. Bernacki, Eur. J. Med. Chem. 1980, 15, 77-84;
14. b) I. Kijima-Suda, Y. Migamala, S. Toyoshima, M. Itoh, T. Osawa, Cancer Res. 1986, 46. 858-862 ;
15. c) S. H. Khan, K. L. Malta, in Glycoconjugats, Composition, Structure, Function (Eds.: H. J. Allen, E. C Kisailus), M. Dekker, New York, 1992, pp. 361-378 and references therein.
16. a) H. Hashimoto, K. Sato, T. Wakabayashi, H. Kodama, Y. Kajihara, Carbohydr. Res. 1993, 247, 179-193;
17. b) M. Imamoto, H. Hashimoto, Tetrahedron Lett. 1996, 37, 451-1454.
18. a) R. G. Kleineidam, T. Schmelter, R. T. Schwarz, R. Schauer, Glycoconjugate J. 1997, 14, 57-66;
19. b) D.H. van den Eijnden, T. J. Martin, R. R. Schmidt, unpublished results;
20. c) G. Dufner, Dissertation, Universitadie;t Konstanz, 1997.
21. a) C. Schaub, B. Müller, R. R. Schmidt, Glycoconjugate J. 1998, 15, 345-354;
22. b) C. Schaub, R. R. Schmidt, Abstract C10, Second European Conference on Carbohydrate Mimics, La Garda (Italy), 1996, and references therein.
23. B. Müller, T. J. Martin, C. Schaub, R. R. Schmidt, Tetrahedron Lett. 1998, 59, 509-512.
24. Recently antisense technology has been investigated in order to decrease sialyltransferase expression: W. Kemmner, K. Hohaus, P. M. Schlag, FEBS Lett. 1997, 409, 347-350.
25. a) J. C. Paulson, J. L. Rearick, R. L. Hill, J. Biol. Chem. 1977, 252, 2363-2371;
26. b) W. D. Klohs, R. J. Bernacki, W. Korytnik, Cancer Res. 1987, 39, 1231-1238.
27. B. A. Horenstein, M. Bruner, J. Am. Chem. Soc. 1996, 118, 10371-10379;
28. b) Biochemistry 1998, 37, 289-297 and references therein.
29. Other examples of transition-state analogues of sugar nucleotides: UDP- Gal: a) K. Frische, Dissertation, Universität Konstanz, 1992; b) K. Frische, R. R. Schmidt, Bioorg. Med. Chem. Lett. 1993, 3, 1747-1750; GDP-Fuc: c) S. Cai, M. R. Strond, S. Hakomori, T. Toyokuni, J. Org. Chem. 1992, 57, 6693-6696.
30. Other examples of transition-state analogues of sugar nucleotides: UDP- Gal: a) K. Frische, Dissertation, Universität Konstanz, 1992; b) K. Frische, R. R. Schmidt, Bioorg. Med. Chem. Lett. 1993, 3, 1747-1750; GDP-Fuc: c) S. Cai, M. R. Strond, S. Hakomori, T. Toyokuni, J. Org. Chem. 1992, 57, 6693-6696.
31. Other examples of transition-state analogues of sugar nucleotides: UDP- Gal: a) K. Frische, Dissertation, Universität Konstanz, 1992; b) K. Frische, R. R. Schmidt, Bioorg. Med. Chem. Lett. 1993, 3, 1747-1750; GDP-Fuc: c) S. Cai, M. R. Strond, S. Hakomori, T. Toyokuni, J. Org. Chem. 1992, 57, 6693-6696.
32. N. B. Tarusova, C. G. Zavgorodnii, T. I. Osipova, Bioorg. Khim. 1986, 11, 802-807.
33. Commercially available from Fluka.
34. T. Morita, Y. Okamoto, H. Sakurai, Bull Chem. Soc. Jpn. 1981. 54, 267-273.
35. F. Amann, Dissertation, Universität Konstanz, 1997.
36. For details, see ref. [9].
37. CSC Chem 3D (MM2).
38. Commercially available from Aldrich.
39. D. J. Whelan, Aust. J. Chem. 1973, 26, 4155-4156.
40. C. L. D. Jenkins, R. L. N. Harris, A. G. McFadden, Biochem. Int. 1986, 12, 619-625.
41. a) P. Meindl, H. Tuppy, Monatsh. Chem. 1965, 96, 803-815;
42. b) ibid. 1969, 100, 1295-1306.
43. W. Bannwarth, A. Trzeciak, Helv. Chim. Acta 1987, 70, 175-186.
44. a) Y. Kajihara, K. Koseki, T. Ebata, H. Kodama, H. Matsusita, H. Hashimoto, Carbohydr. Res. 1994, 264, Cl-C5;
45. b)J. Org. Chem. 1995, 60, 5732-5735.
46. D. B. Dess, J. C. Martin, J. Am. Chem. Soc. 1991, 113, 7277-7287.
47. P. Deslongchamps, in Stereoelectronic Effects in Organic Chemistry, Pergamon, Oxford, 1983.
48. A. C. Satterthwait, F. H. Westheimer, J. Am. Chem. Soc. 1978, 100, 3197-3203.
49. H. J. Gross, U. Rose, J. M. Krause, J. C. Paulson, K. Schmid, R. E. Feeney, R. Brossmer, Biochemistry 1989, 28, 7386-7392.
50. J. A. Dale, H. S. Mosher, J. Am. Chem. Soc. 1973, 95, 512-519.
51. F. Hammerschmidt, Y.-F. Li, Tetrahedron 1994, 50, 10253-10264 and references therein.